Evidence map›Paper›PMID 31109981›Full record

ArticleAntimicrobial agents and chemotherapy2019

Emergence of Oxacillin Resistance in Stealth Methicillin-Resistant

Richard V Goering, Erin A Swartzendruber, Anne E Obradovich, Isabella A Tickler, Fred C Tenover

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Methicillin-resistant Staphylococcus aureus.Nature reviews. Disease primers · 2026
    Review
  3. An Achilles' heel for methicillin-resistantAntimicrobial agents and chemotherapy · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Oxacillin-susceptible methicillin-resistantJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Molecular detection of multidrug and methicillin resistance inOne health (Amsterdam, Netherlands) · 2024
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Characterization of SCCAntimicrobial agents and chemotherapy · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Richard V GoeringDepartment of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska, USA richardgoering@creighton.edu.
Erin A SwartzendruberDepartment of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska, USA.
Anne E ObradovichDepartment of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska, USA.
Isabella A TicklerCepheid, Sunnyvale, California, USA.
Fred C TenoverCepheid, Sunnyvale, California, USA.
Creighton University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsCefoxitinDNA, BacterialDrug Resistance, Multiple, BacterialHumansMethicillinMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsOxacillinPenicillin-Binding ProteinsStaphylococcal InfectionsAnti-Bacterial AgentsBacterial ProteinsCefoxitinDNA, BacterialmecA protein, Staphylococcus aureusMethicillinOxacillinPenicillin-Binding Proteinsemergence of resistancemecAMRSAoxacillin susceptiblewhole-genome sequencing

Identifiers

PMID31109981
PMCPMC6658785
OpenAlexW2945025158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.